Skip to content

Exercise during breast cancer chemotherapy: A telehealth pilot feasibility study

Investigating the effect of multidisciplinary interventions on exercise uptake during early breast cancer treatment: a feasibility study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622001254785
Enrollment
1
Registered
2022-09-19
Start date
2022-09-07
Completion date
2023-10-04
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to assess the feasibility of an online group exercise and education program for women with breast cancer who are receiving chemotherapy treatment. Who is it for? You may be eligible for this study if you are a female aged 18 or older, you have been diagnosed with early stage breast cancer (stage I, II or IIIA), you are scheduled to undergo chemotherapy but you have not yet started, or you have started chemotherapy within the last 4 weeks, and you have a reliable internet connection together with devices to enable video-conferencing. Study details All participants who choose to enrol in this study will undergo a 12 week exercise and education program that is delivered entirely by telehealth. Participants will attend two weekly exercise classes which run for 45 minutes and one educational class each fortnight, which runs for 1 hour including a 15 minute Q&A component. Exercise classes will include a combination of aerobic and resistance training exercises, while the educational sessions will cover topics including how to exercise safely while you are receiving chemotherapy, how to look after your mental health and strategies that may assist you, guidance on maintaining a healthy diet while you are receiving chemotherapy and after treatment has finished. Once this 12 week exercise program is completed, you will receive 12 weeks of tapered phone calls from the research assistant involved in this study to encourage you to maintain exercise levels. It is hoped this research will demonstrate that it is possible and acceptable to deliver these therapies to breast cancer patients remotely via telehealth. If this study shows that delivery of this program by telehealth is successful, it may lead to a larger future study of telehealth delivery of these therapies to a greater number of breast cancer patients, and would particularly benefit those patients who are not able to travel to hospital on a weekly basis.

Interventions

A multidisciplinary exercise induction program delivered by telehealth, to improve exercise, self-efficacy and quality of life in breast cancer patients undergoing chemotherapy. The program aims to assist participants to meet the Clinical Oncology Society of Australia guidelines for exercise which involve at least 150 minutes of moderate intensity aerobic exercise per week in addition to two to three resistance exercise sessions per week. There will be bi-weekly, virtual exercise classes across

A multidisciplinary exercise induction program delivered by telehealth, to improve exercise, self-efficacy and quality of life in breast cancer patients undergoing chemotherapy. The program aims to assist participants to meet the Clinical Oncology Society of Australia guidelines for exercise which involve at least 150 minutes of moderate intensity aerobic exercise per week in addition to two to three resistance exercise sessions per week. There will be bi-weekly, virtual exercise classes across a 12 week period delivered through Microsoft Teams which will be supervised by a physiotherapist. Classes will commence once three participants have been recruited and the maximum group size will be five participants at any one time. The exercises completed during the classes will be individualized according to each patient depending on their baseline fitness and comorbidities during an initial physiotherapy assessment and will be based off the exercises recommended in the Cancer Council booklet, 'Exercise for People Living with Cancer'. Each exercise class will be 45 minutes in duration and will consist of a warm up and warm down component and a combination of the aerobic exercises prescribed, examples include jumping jacks and brisk walking on the spot and strength based exercises prescribed, examples of these include, bird-dog, pelvic tilt and bicep curl with dumbells. Attendance will be measured through a session attendance checklist and reason for absence will also be documented. In addition, to meet the 150 minutes of exercise recommended by COSA, participants will be encouraged to complete a daily exercise routine in their own time at home and record the type and quantity of exercise, either in a paper-based logbook or via the Physitrack app, for the duration of the study. This home exercise will consist of the same types of resistance and aerobic exercise completed in the bi-weekly classes. There will be also fortnightly, virtual educational classes to supplement the exercise classes, six in total, each delivered by a clinical member of a multidisciplinary team through Microsoft Teams. These educational sessions will discuss topics that are pertinent to cancer. Three sessions will be delivered by the clinical psychologist, one will be talk about mindfulness, the other session will be a talk about body image and another session will be a talk about anxiety education and management. There will be one session delivered by a dietician who will present a talk about nutrition during cancer treatment. There will be one session delivered by an occupational therapist who will present a talk about fatigue management. There will be one session delivered by a physiotherapist who will present a talk about maintaining physical activity. There will be informational materials provided from the Cancer Council website. These sessions will last for approximately 1 hour, including 15 minutes dedicated to a Q&A component. Attendance will be measured through a session attendance checklist and reason for absence will also be documented. After these 12 weeks of exercise and educational classes, there will be tapered phone calls by the research assistant to encourage maintenance of exercise levels and continual recording of daily exercise via the logbook/Physitrack app and to communicate back with the study physiotherapist if modifications need to be made to the exercise program. These phone calls will span a 12 week period and will begin at one phone call a week for four weeks, then one phone call once a month for two months. There will be six phone calls in total.

Sponsors

St Vincent's Hospital Sydney
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Adults aged 18 years and over • Early stage female breast malignancy (stage I, II or IIIA) • Planned for chemotherapy but has not yet commenced it; or is within 4 weeks of commencement of chemotherapy • Able to provide written informed consent • Access to an internet connection with camera and audio to enable telehealth (e.g. via a smartphone, tablet, desktop or laptop device) • Able to utilise telehealth technology

Exclusion criteria

• Medically unfit to participate in a home-based exercise programme, as assessed by either a medical oncologist or rehabilitation physician • New York Heart Association Class IV heart failure • Type I or type 2 respiratory failure • Cardiac, respiratory or neurological symptoms that are being actively investigated • Unable to mobilise independently (i.e. requires assistance to stand and walk) • Non-English speaking patients. Because in-depth communication between participants and physiotherapist, and attendance at group education sessions by telehealth, are an essential component of this study, and due to the limited budget of this pilot study, using a translator will be not be feasible. • Severe uncorrected hearing impairment – as this will prevent effective engagement in the group telehealth intervention

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026